Cyclic vomiting syndrome (CVS) is a type of functional gastrointestinal disorder (FGID) that arises from a breakdown in communication between the brain and the gastrointestinal (GI) tract, causing a range of GI-related symptoms to occur.

Characterized by sudden, recurring episodes of intense nausea and vomiting, CVS exhibits three distinctive traits: abrupt onset, recurrence of similar episodes, and periods of remission in between.

Potential Triggers of CVS

The root cause of CVS remains a mystery, but it is frequently connected to a background of migraine headaches. Treatments designed for migraines have shown promise in forestalling CVS attacks.

Various physical or emotional stressors might provoke CVS episodes, and dietary factors could also contribute to symptom flare-ups.

CVS has also been tied to the misuse of cannabis (marijuana), leading to a condition labeled as “cannabinoid hyperemesis.”

Incidence and Assessment of CVS

CVS is more prevalent during childhood, typically emerging between the ages of 3 and 7. Diagnosis often hinges on medical history and familial tendencies, as CVS is commonly intertwined with migraines.

Indications and Manifestations of CVS

Individuals with CVS undergo cycles of vomiting episodes that can persist from a few hours to multiple days. Symptoms may encompass nausea, abdominal pain, diarrhea, headaches, and loss of appetite.

Vomiting spells generally mirror one another, and individuals may enjoy periods of well-being in between occurrences.

When to Pursue Medical Intervention

If a child with CVS displays signs of dehydration, vomits blood, runs a fever exceeding 101°F, or endures prolonged vomiting, immediate medical help should be sought.

Treatment Approaches for CVS

Managing CVS involves interventions to halt episodes as they initiate and strategies to avert future occurrences. Anti-nausea medications, anti-anxiety drugs, and intravenous fluids may be utilized, particularly in severe cases.

Prophylactic medications such as cyproheptadine, propranolol, and amitriptyline can mitigate the frequency and severity of CVS episodes in select patients.

Cyclic vomiting syndrome (CVS) entails recurrent bouts of vomiting that commence abruptly and follow a predictable pattern, with intervals of good health in between. Diagnosis involves an evaluation of history, physical examination, and exclusion of alternative conditions. CVS impacts around 1 in 33,000 children, occasionally hindering daily activities.

The precise cause of CVS remains elusive, though research suggests a strong association with migraines. Probable causes include dysautonomia, specific mitochondrial DNA mutations, and stress that triggers the vomiting reflex.

Symptoms of CVS encompass recurrent vomiting episodes beginning suddenly with nausea and progressing to vomiting, often waking the individual from sleep. Episodes conform to a familiar pattern, resembling past experiences, and may involve abdominal discomfort, diarrhea, and headaches. Severe dehydration warrants medical attention.

Children affected by CVS frequently have migraines or a family history of migraines. Diagnosis relies predominantly on symptoms, with tests conducted to rule out alternative conditions.

Medications can assist in managing CVS symptoms in cases of frequent episodes. Treatment may include migraine medications, anti-emetic drugs, and pain relievers. Severe instances might necessitate hospitalization for intravenous fluids and medication.

Preventive measures for CVS involve pinpointing triggers like stress, sleep deprivation, specific foods, and ensuring adequate hydration during episodes. Support services are available for individuals struggling to cope with symptoms.

Informative resources and support for CVS are accessible through various channels, including published literature. Ongoing research into CVS in children centers on comprehending the syndrome and refining management strategies.

1. Bar O., Ebenau L., Weiner K., Mintz M., Boles R.G. Whole exome/genome sequencing in cyclic vomiting syndrome suggests a model of elevated intracellular cations and mitochondrial dysfunction. Front Neurol 2023; 14: 1-17. DOI: 10.3389/fneur.2023.1151835
2. Sticht M.A., Limebeer C.L., Rafla B.R., Abdullah R.A., Poklis J.L., Niphakis M.J. et al. Endocannabinoid regulation of nausea is mediated by 2-arachidonoylglycerol (2-AG) in the rat visceral insular cortex. Neuropharmacology 2016; 102: 92-102. DOI: 10.1016/j.neuropharm.2015.10.039
3. Ziganshina A.A. Gastrointestinal manifestations of mitochondrial dysfunction. Rossiyskiy vestnik pediatrii 2016; 61(6): 38-42. (in Russ.) DOI: 10.21508/1027-4065-2016-61-6-38-42
4. Venkatesan T., Zaki E.A., Kumar N., Sengupta J., Ali M., Malik B. et al. Quantitative pedigree analysis and mitochondrial DNA sequence variants in adults with cyclic vomiting syndrome. BMC Gastroenterol 2014; 14: 181. DOI: 10.1186/1471-230X-14-181
5. Gordan N. Recurrent vomiting in childhood, especially of neurological origin. Dev Med Child Neurol 1994; 36(5): 463-470. DOI: 10.1111/j.1469-8749.1994.tb11873.x
6. Rashed H., Abell T.L., Familoni B.O., Cardoso S. Autonomic function in cyclic vomiting syndrome and classic migraine. Dig Dis Sci 1999; 44: 74-78.
7. Chelimsky G., Madan S., Alshekhlee A., Heller E., McNeeley K., Chelimsky T. A comparison of dysautonomias comorbid with cyclic vomiting syndrome and with migraine. Gastroenterol Res Pract 2009; 2009: 701019. DOI: 10.1155/2009/701019
8. Khasawinah T.A., Ramirez A., Berkenbosch J.W., Tobias J.D. Preliminary experience with dexmedetomidine in the treatment of cyclic vomiting syndrome. Am J Ther 2003; 10(4): 303-307. DOI: 10.1097/00045391-200307000-00012
9. Sato T. Prevalence of Syndrome of ACTH-ADH Discharge in Japan. Clin Pediatr Endocrinol 1993; 2(1): 7-12. DOI:10.1297/cpe.2.7
10. Chow S., Goldman R.D. Treating children’s cyclic vomiting. Can Fam Physician 2007; 53(3): 417-419.